Bristol-Myers Squibb Company
Antibody Compositions and Methods of Use Thereof

Last updated:

Abstract:

The disclosure provides pharmaceutical compositions comprising an antibody and at least two antioxidants. In some aspects, pharmaceutical composition is formulated for subcutaneous delivery. In some aspects, the pharmaceutical composition further comprises an endoglycosidase hydrolase enzyme. Other aspects of the present disclosure are directed to methods of subcutaneously delivering the pharmaceutical composition.

Status:
Application
Type:

Utility

Filling date:

27 Dec 2021

Issue date:

28 Jul 2022